Saberian E, Jenča A, Zafari Y, Jenča A, Petrášová A, Zare-Zardini H, et al. Scaffold application for bone regeneration with stem cells in dentistry: literature review. Cells. 2024;13(12):1065. https://doi.org/10.3390/cells13121065.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Saberian E, Jenča A, Seyfaddini R, Jenča A, Zare-Zardini H, Petrášová A, et al. Comparative analysis of osteoblastic responses to titanium and alumina-toughened zirconia implants: an in vitro study. Biomolecules. 2024;14(6):719. https://doi.org/10.3390/biom14060719.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Saberian E, Jenča A, Petrášová A, Zare-Zardini H, Ebrahimifar M. Application of scaffold-based drug delivery in oral cancer treatment: a novel approach. Pharmaceutics. 2024;16(6):802. https://doi.org/10.3390/pharmaceutics16060802.

Article  PubMed  PubMed Central  Google Scholar 

Parizad G, Bagheri R, Elham S, Andrej J, Adriána P, Janka J, et al. Enhancing cisplatin delivery via liposomal nanoparticles for oral cancer treatment. Ind J Clin Biochem. 2024;1:1. https://doi.org/10.1007/s12291-024-01239-3.

Article  CAS  Google Scholar 

Silva S, Hier M, Mlynarek A, Kowalski L, Alaoui-Jamali M. Recurrent oral cancer: current and emerging therapeutic approaches. Front Pharmacol. 2012;3:1. https://doi.org/10.3389/fphar.2012.00149.

Article  Google Scholar 

Poy D, Akbarzadeh A, Ebrahimi Shahmabadi H, Ebrahimifar M, Farhangi A, Farahnak Zarabi M, Akbari A, Saffari Z, Siami F. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing; cisplatin: an in vitro study. Chem Biol Drug Des. 2016;88(4):568–73. https://doi.org/10.1111/cbdd.1278636.

Article  PubMed  CAS  Google Scholar 

Tchounwou PB, Dasari S, Noubissi FK, Ray P, Kumar S. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. J Exp Pharmacol. 2021;13:303–28. https://doi.org/10.2147/JEP.S267383.

Article  PubMed  PubMed Central  Google Scholar 

Dasari S, Tchounwou P. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–78. https://doi.org/10.1016/j.ejphar.2014.07.025.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73(9):994–1007. https://doi.org/10.1038/sj.ki.5002786.

Article  PubMed  CAS  Google Scholar 

Ebrahimifar M, Hasanzadegan Roudsari M, Kazemi SM, Ebrahimi Shahmabadi H, Kanaani L, Alavi SA, Izadi Vasfi M. Enhancing effects of curcumin on cytotoxicity of paclitaxel, methotrexate and vincristine in gastric cancer cells. Asian Pac J Cancer Prev. 2017;18(1):65–8. https://doi.org/10.2234/APJCP.2017.18.1.6537.

Article  PubMed  PubMed Central  Google Scholar 

Srivastava N, Srivastava R. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine. 2019;52:117–28. https://doi.org/10.1016/j.phymed.2018.09.224.

Article  PubMed  CAS  Google Scholar 

Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W, Yang D, Yang A, Yu Y. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway. Oncol Rep. 2018;39(3):1523–31. https://doi.org/10.3892/or.2018.6188.

Article  PubMed  CAS  Google Scholar 

Almatroodi S, Syed M, Rahmani A. Potential therapeutic targets of curcumin, most abundant active compound of turmeric spice: role in the management of various types of cancer. Recent Pat Anticancer Drug. 2020;16(1):3–29. https://doi.org/10.2174/1574892815999201102214602.

Article  CAS  Google Scholar 

Hegde M, Girisa S, BharathwajChetty B, Vishwa R, Kunnumakkara A. Curcumin formulations for better bioavailability: What we learned from clinical trials thus far? ACS Omega. 2023;8(12):10713–46. https://doi.org/10.1021/acsomega.2c07326.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cheng Y, Zhao P, Wu Sh, Yang T, et al. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. Int J Pharm. 2018;545(1–2):261–73. https://doi.org/10.1016/j.ijpharm.2018.05.007.

Article  PubMed  CAS  Google Scholar 

Mohamadi N, Kazemi SM, Mohammadian M, Toofani Milani A, Moradi Y, Yasemi M, Ebrahimifar M, Mazloumi Tabrizi M, Ebrahimi Shahmabadi H, AkbarzadehKhiyavi A. Toxicity of cisplatin-loaded poly butyl cyanoacrylate nanoparticles in a brain cancer cell line: anionic polymerization results. Asian Pac J Cancer Prev. 2017;18(3):629–32. https://doi.org/10.22034/APJCP.2017.18.3.62938.

Article  PubMed  PubMed Central  Google Scholar 

Amiri B, Ebrahimifar M, Saffari Z, Akbarzadeh A, Soleimani E, Chiani M. Preparation, characterization and cytotoxicity of silibinin-containing nanoniosomes in T47D human breast carcinoma cells. Asian Pac J Cancer Prev. 2016;17(8):3835–40.

PubMed  Google Scholar 

Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22–36. https://doi.org/10.1016/j.jconrel.2014.04.015.

Article  PubMed  CAS  Google Scholar 

Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharmacol Sci. 2018;2018(1):6847971. https://doi.org/10.1155/2018/6847971.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Khan D, Bashir S, Correia A, Khan M, Figueiredo P, Santos H, Peltonen L. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes. Int J Pharm. 2019;572: 118764. https://doi.org/10.1016/j.ijpharm.2019.118764.

Article  PubMed  CAS  Google Scholar 

Momekova D, Gugleva V, Petrov P. Nanoarchitectonics of multifunctional niosomes for advanced drug delivery. ACS Omega ACS Omega. 2021;6(49):33265–73. https://doi.org/10.1021/acsomega.1c05083.

Article  PubMed  CAS  Google Scholar 

Kumar S, Kaur D. Niosome as an innovative drug delivery system. Central Asian J Med Nat Sci. 2020;1(1):1–15. https://doi.org/10.17605/cajmns.v1i1.19.

Article  Google Scholar 

Ge X, Wei M, He S, Yuan W. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics. 2019;11(2):55. https://doi.org/10.3390/pharmaceutics11020055.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tavano L, Muzzalupo R. Multi-functional vesicles for cancer therapy: the ultimate magic bullet. Colloids Surf B Biointerfaces. 2016;147:161–71. https://doi.org/10.1016/j.colsurfb.2016.07.060.

Article  PubMed  CAS  Google Scholar 

Tardi PG, Dos Santos N, Harasym TO, Johnstone SA, Zisman N, Tsang AW, Bermudes DG, Mayer LD. Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo. Mol Cancer Ther. 2019;8(8):2266–75. https://doi.org/10.1158/1535-7163.MCT-09-0243.

Article  CAS  Google Scholar 

Maswadeh H, Khan A, Alorainy M, Al-Wabel N, Demetzos C. Concomitant delivery of doxorubicin and cisplatin through liposome-based thermosensitive nanoparticles: perspective in the treatment of cancer in animal models. Am J Cancer Res. 2023;13(2):379–93.

PubMed  PubMed Central  CAS  Google Scholar 

Harsin A, Firozian F, Soleimani M, Mehri F, Ranjbar A. Evaluation of ascorbic acid niosomes as potential detoxifiers in oxidative stress-induced HEK-293 cells by arsenic trioxide. Iran J Pharm Res. 2022;21(1): e127038. https://doi.org/10.5812/ijpr-127038.

Article  CAS  Google Scholar 

Li C, Ge X, Wang L. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: a synergistic combination nanotherapy for cervical cancer. Biomed Pharmacother. 2017;86:628–36. https://doi.org/10.1016/j.biopha.2016.12.042.

Article  PubMed